Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9

National Institute on Drug Abuse (NIDA)60 enrolled

Overview

The purpose of this study is to evaluate the safety and efficacy of flupenthixol and haloperidol for cocaine dependence in individuals with schizophrenia/schizoaffective illness.

Study Type

INTERVENTIONAL

Purpose

TREATMENT

Enrollment

Conditions

Interventions

FlupenthixolDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Please contact site for information.

Locations (1)

New York State Psychiatric Institute

New York, New York, United States

Outcomes

Primary Outcomes

Side effects

Drug use

Psychiatric symptoms

Cocaine craving

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.